CDKN2A HD was associated with a dismal outcome in IDH-mutant astrocytomas (p < 0.0001 for PFS and p = 0.004 for OS) in both univariate and multivariate analyses. This evidence concerns the gene CDKN2A and astrocytoma (excluding glioblastoma).